The company attributed an estimated $135 million in lost sales to June’s NotPetya cyberattack, which temporarily led Merck to halt drug production. Remediation costs related to the cyberattack also contributed to the company’s $2.4 billion in marketing and administrative expenses, a similar expense to the $2.39 billion Merk reported during the third quarter of 2016.
The worldwide cyberattack NotPetya infected computer systems in more than 60 countries June 27. Merck was the first major U.S. company to acknowledge NotPetya had compromised its computer network, which it confirmed via Twitter June 27.
More articles on supply chain:
7 drug, devicemakers in the headlines
Is Amazon also looking to enter the medical device business?
FDA hires Mylan exec as senior communications adviser
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.